Veracyte (VCYT) Non-Current Deferred Tax Liability (2014 - 2026)
Veracyte's (VCYT) quarterly Non-Current Deferred Tax Liability came in at $636000.0 in Q1 2026, down 48.79% year-on-year from $1.2 million in Q1 2025, and down 1.55% quarter-over-quarter from $646000.0 in Q4 2025.
Veracyte (VCYT) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Veracyte has disclosed Non-Current Deferred Tax Liability across 10 years of filings, most recently posting $636000.0 for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $636000.0, down 48.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $636000.0 (down 48.79% YoY), and the FY2025 annual result was $646000.0, down 98.17% from the prior year.
- Non-Current Deferred Tax Liability came in at $636000.0 for Q1 2026 at Veracyte, down from $646000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $36.7 million in Q4 2022 to a low of $636000.0 in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $3.6 million (2023), against an average of $7.8 million.
- Across the five-year window, Non-Current Deferred Tax Liability jumped 564.4% in 2022 and plunged 98.17% in 2025, its largest moves.
- Veracyte's Non-Current Deferred Tax Liability stood at $36.7 million in 2022, then sank by 35.65% to $23.6 million in 2023, then soared by 48.89% to $35.2 million in 2024, then tumbled by 98.17% to $646000.0 in 2025, then dropped by 1.55% to $636000.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $636000.0 (Q1 2026), $646000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Veracyte | 3.91 Bn | 3.65 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 636,000.00 |
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 23.65 Mn |
| Dec 31, 2023 | 23.65 Mn |